An experimental animal study found that after blocking Gal-3 function, structural remodeling of the atrial heart, characterized by excessive collagen deposition resulting from interstitial cardiac fibrosis induced by TGF-β/Smad3 signaling pathway, was significantly mitigated [8]. The gene discussed is SMAD3; the disease is Interstitial cardiac fibrosis.